Submit your email to push it up the queue
Kalbe International Pte Ltd, a prominent player in the pharmaceutical and healthcare industry, is headquartered in Singapore (SG) and operates extensively across Southeast Asia. Founded in 1966, the company has established itself as a leader in the production and distribution of high-quality pharmaceuticals, nutritional products, and consumer health items. With a commitment to innovation, Kalbe International offers a diverse range of core products, including prescription medications, over-the-counter drugs, and nutritional supplements, all designed to enhance health and well-being. The company is recognised for its rigorous quality standards and dedication to research and development, which have positioned it favourably in the competitive market. Kalbe International's notable achievements include significant market share in various therapeutic areas, underscoring its reputation as a trusted provider in the healthcare sector.
How does Kalbe International Pte Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Kalbe International Pte Ltd.'s score of 40 is higher than 64% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Kalbe International Pte Ltd., headquartered in Singapore (SG), currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of PT Kalbe Farma Tbk., which may influence its climate commitments and emissions reporting. As of now, there are no documented reduction targets or climate pledges from Kalbe International Pte Ltd. However, emissions data and performance metrics may be inherited from its parent company, PT Kalbe Farma Tbk., at a cascade level of 1. This means that any climate initiatives or emissions reductions reported by PT Kalbe Farma Tbk. could reflect on Kalbe International's overall climate strategy. In the absence of specific emissions figures, it is essential to note that Kalbe International Pte Ltd. is part of a broader industry context where companies are increasingly focusing on sustainability and carbon footprint reduction. The lack of direct emissions data highlights the need for enhanced transparency and commitment to climate action within the organisation.
Access structured emissions data, company-specific emission factors, and source documents
2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|
Scope 1 | 14,233,290 | 00,000,000 | 00,000,000 | 00,000,000 |
Scope 2 | 63,725,950 | 00,000,000 | 00,000,000 | 00,000,000 |
Scope 3 | - | - | - | - |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Kalbe International Pte Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.